Pharmacokinetics of 20 mg Teduglutide in Subjects With Moderately Impaired Hepatic Function Compared to Healthy Subjects With Normal Hepatic Function - Related Studies

Beta test our new site.

Home Search Study Topics Glossary

Pharmacokinetics of 20 mg Teduglutide in Subjects With Moderately Impaired Hepatic Function Compared to Healthy Subjects With Normal Hepatic Function

This study has been completed.

Study NCT00819468 Information provided by NPS Pharmaceuticals

First Received on January 8, 2009. No Changes Posted

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Hepatic Impairment

Additional conditions recognized in this trial

Liver Diseases

More general conditions related to this trial

Interventions listed in this trial

teduglutide

Sponsors listed in this trial

NPS Pharmaceuticals